ACADIA Pharmaceuticals Inc. (ACAD) vs Arcutis Biotherapeutics, Inc. (ARQT)
- ACADIA Pharmaceuticals Inc. ACAD 19.12 −2.99%
- Arcutis Biotherapeutics, Inc. ARQT 28.82 −0.96%
ACADIA Pharmaceuticals Inc. and Arcutis Biotherapeutics, Inc. are both Biotechnology companies. ACADIA Pharmaceuticals Inc. and Arcutis Biotherapeutics, Inc. are of similar size ($3.7B and $3.4B). ACADIA Pharmaceuticals Inc. trades at the lower P/E: 8.5× against 131×. Arcutis Biotherapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against 11.8%. ACADIA Pharmaceuticals Inc. has the higher net margin (33.4% vs 6.15%) and the lower return on invested capital (15.4% vs 23.6%). Across the 19 metrics below, ACADIA Pharmaceuticals Inc. leads on 14 and Arcutis Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ACAD | ARQT | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.13% | 91.14% | 65.16% |
| Operating margin | 7.59% | 7.38% | 0.00% |
| Net margin | 33.42% | 6.15% | 0.00% |
| Free cash flow margin | 12.79% | 8.42% | 0.00% |
| Return on equity | 35.74% | 15.86% | (56.36%) |
| Return on assets | 25.64% | 6.78% | (48.04%) |
| Return on invested capital | 15.42% | 23.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack